Parametric response mapping of dynamic CT as an imaging biomarker to distinguish viability of hepatocellular carcinoma treated with transcatheter arterial chemoembolization

被引:10
作者
Choi, Seung Joon [1 ]
Kim, Jonghoon [2 ]
Seo, Jongbum [3 ]
Kim, Hyung Sik [1 ]
Lee, Jong-min [4 ]
Park, Hyunjin [2 ]
机构
[1] Gachon Univ, Gil Hosp, Dept Radiol, Inchon, South Korea
[2] Sungkyunkwan Univ, Sch Elect & Elect Engn, Suwon, South Korea
[3] Yonsei Univ, Dept Biomed Engn, Wonju, South Korea
[4] Hanyang Univ, Dept Biomed Engn, Seoul 133791, South Korea
来源
ABDOMINAL IMAGING | 2014年 / 39卷 / 03期
基金
新加坡国家研究基金会;
关键词
Hepatocellular carcinoma; Parametric response mapping; Automatic classifier; Transcatheter arterial chemoembolization; Dynamic CT; Longitudinal exam; TRANSARTERIAL CHEMOEMBOLIZATION; LIPIODOL-CHEMOEMBOLIZATION; EMBOLIZATION; THERAPY; MAP; LIVER; RECURRENCES; COMBINATION; MANAGEMENT; SORAFENIB;
D O I
10.1007/s00261-014-0087-z
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Accurate assessment of viability of hepatocellular carcinoma (HCC) after transcatheter arterial chemoembolization (TACE) is important for therapy planning. The purpose of this study is to determine the diagnostic value of a novel image analysis method called parametric response mapping (PRM) in predicting viability of tumor in HCC treated with TACE for dynamic CT images. 35 patients who had 35 iodized-oil defect areas (IODAs) in HCCs treated with TACE were included in our study. These patients were divided into two groups, one group with viable tumors (n = 22) and the other group with non-viable tumors (n = 13) in the IODA. All patients were followed up using triple-phase dynamic CT after the treatment. We compared (a) manual analysis, (b) using PRM results, and (c) using PRM results with automatic classifier to distinguish between two tumor groups based on dynamic CT images from two longitudinal exams. Two radiologists performed the manual analysis. The PRM approach was implemented using prototype software. We adopted an off-the-shelf k nearest neighbor (kNN) classifier and leave-one-out cross-validation for the third approach. The area under the curve (AUC) values were compared for three approaches. Manual analysis yielded AUC of 0.74, using PRM results yielded AUC of 0.84, and using PRM results with an automatic classifier yielded AUC of 0.87. We improved upon the standard manual analysis approach by adopting a novel image analysis method of PRM combined with an automatic classifier.
引用
收藏
页码:518 / 525
页数:8
相关论文
共 50 条
  • [11] Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma
    Michitoshi Takano
    Takashi Kokudo
    Yoshihiro Miyazaki
    Yumiko Kageyama
    Amane Takahashi
    Katsumi Amikura
    Hirohiko Sakamoto
    World Journal of Gastroenterology, 2016, (42) : 9445 - 9450
  • [12] Parametric response mapping of contrast-enhanced biphasic CT for evaluating tumour viability of hepatocellular carcinoma after TACE
    Hinrichs, Jan B.
    Shin, Hoen-Oh
    Kaercher, Daniel
    Hasdemir, Davut
    Murray, Tim
    Kaireit, Till
    Lutat, Carolin
    Vogel, Arndt
    Meyer, Bernhard C.
    Wacker, Frank K.
    Rodt, Thomas
    EUROPEAN RADIOLOGY, 2016, 26 (10) : 3447 - 3455
  • [13] Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging
    Chen, Xiangyu
    Xiao, Enhua
    Shu, Dianshuang
    Yang, Chengzhi
    Liang, Bin
    He, Zhong
    Bian, Dujun
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2014, 26 (01) : 109 - 113
  • [14] Sarcopenia as a prognostic factor in patients with hepatocellular carcinoma treated with transcatheter arterial chemoembolization plus sorafenib
    Wang, Rujian
    Wang, Ligang
    Jiang, Yutian
    Dong, Mei
    Li, Mei
    Sun, Ping
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2024, 20 (04) : 1208 - 1213
  • [15] Hepatocellular carcinoma associated with budd-chiari syndrome: imaging features and transcatheter arterial chemoembolization
    Liu, Feng-Yong
    Wang, Mao-Qiang
    Duan, Feng
    Fan, Qing-Sheng
    Song, Peng
    Wang, Yan
    BMC GASTROENTEROLOGY, 2013, 13
  • [16] Delayed enhancement of hepatocellular carcinoma on dynamic CT: sign of extrahepatic collaterals after transcatheter arterial chemoembolization or transcatheter arterial chemoinfusion
    Katoh, T
    Mitani, M
    Noma, K
    Sunayama, T
    Nakano, S
    Toyama, Y
    Ohkawa, M
    ABDOMINAL IMAGING, 2002, 27 (01): : 34 - 39
  • [17] Influencing factors related to transcatheter arterial chemoembolization for hepatocellular carcinoma patients achieved tumor response
    Shao, Hongyan
    Deng, Juan
    Xie, Luping
    Zheng, Qiwen
    Zou, Bihui
    Deng, Jun
    Zhang, Tianqi
    He, Jingjing
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2022, 18 (02) : 560 - 566
  • [18] Novel imaging biomarkers of response to transcatheter arterial chemoembolization in hepatocellular carcinoma patients
    Favelier, Sylvain
    Estivalet, Louis
    Pottecher, Pierre
    Loffroy, Romaric
    CHINESE JOURNAL OF CANCER RESEARCH, 2015, 27 (06) : 611 - 616
  • [19] Prognostic factors of hepatocellular carcinoma patients with portal vein tumor thrombosis treated with transcatheter arterial chemoembolization
    Liang, Hongyuan
    Cui, Peng
    Guo, Qiyong
    Mao, Xiaonan
    Wen, Feng
    Sun, Wei
    Shan, Ming
    Lu, Zaiming
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2017, 13 (05) : E331 - E341
  • [20] Prediction of Therapeutic Response of Hepatocellular Carcinoma to Transcatheter Arterial Chemoembolization Based on Pretherapeutic Dynamic CT and Textural Findings
    Park, Hyun Jeong
    Kim, Jung Hoon
    Choi, Seo-youn
    Lee, Eun Sun
    Park, Sang Joon
    Byun, Jae Young
    Choi, Byung Ihn
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2017, 209 (04) : W211 - W220